  To evaluate ( 1) the cellular composition of canine ACP ™ including using two different preparation protocols with variations on centrifugation time , ( 2) the effect of different activation protocols on the transforming growth factor ( TGF)- β1 content in the ACP , and ( 3) patient factors that might influence platelet concentration of the ACP. ACP was made with blood from 15 dogs using a manufacturer-recommended protocol. Each ACP sample was divided into three aliquots that were activated with calcium chloride ( CaCl